Nocturnal growth hormone release in children with short stature and atopic dermatitis

T. J. David, A. P. Ferguson, R. W. Newton

    Research output: Contribution to journalArticlepeer-review

    Abstract

    This study was designed to test the hypothesis that children with atopic dermatitis and short stature fail to release growth hormone after falling asleep. Peak serum growth hormone response to arginine was compared with peak growth hormone concentration during sleep in 6 children with atopic dermatitis and short stature (> 3 SD below the mean) aged 7 to 12 years, and 5 control children aged 9 to 12 years without atopic dermatitis or asthma but with unexplained short stature (> 3 SD below the mean). All 5 control children achieved normal levels of growth hormone after falling asleep, whereas 3 of the 6 children with dermatitis did not. All patients with dermatitis were capable of releasing growth hormone after arginine stimulation. The results suggest that in some prepubertal children with atopic dermatitis and short stature there may be an impairment of growth hormone release during stage 4 sleep.
    Original languageEnglish
    Pages (from-to)229-231
    Number of pages2
    JournalActa Dermato-Venereologica
    Volume71
    Issue number3
    Publication statusPublished - 1991

    Fingerprint

    Dive into the research topics of 'Nocturnal growth hormone release in children with short stature and atopic dermatitis'. Together they form a unique fingerprint.

    Cite this